Laboratory evaluation in neck pain

Physical Medicine and Rehabilitation Clinics of North America

Volumn 14, Issue 3, 2003, Pages 589-604

  Dreyer, Susan J ^a,b,c   Boden, Scott D ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID TRANSFER RNA LIGASE; ANTIINFLAMMATORY AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; CALCIUM; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHORUS; RHEUMATOID FACTOR; URIC ACID; URICOSURIC AGENT;

ANAMNESIS; ANTIBODY DETECTION; CANCER DIAGNOSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; COMPLEMENT BLOOD LEVEL; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRUG MONITORING; ERYTHROCYTE SEDIMENTATION RATE; FIBROMYALGIA; GASTROINTESTINAL TOXICITY; GOUT; HUMAN; INFECTION; LABORATORY DIAGNOSIS; LABORATORY TEST; LIVER TOXICITY; MENINGITIS; NECK PAIN; NEEDLE BIOPSY; NEPHROTOXICITY; PAGET BONE DISEASE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; POLYMYOSITIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIAL FLUID;

EID: 0043068103     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-9651(03)00037-8     Document Type: Review

References (29)

1. Borenstein DG, Wiesel S, Boden SD. Laboratory tests, In: Borenstein DG, Wiesel S, Boden SD, editors. Neck pain: medical diagnosis and comprehensive management. Philadelphia: W.B. Saunders; 1996. p. 99-107.
2. Borenstein DG. Musculoskeletal signs and symptoms. C. Disorders of the low back and neck. In: Klippel JH, editor. Primer on the rheumatic diseases. 12th edition. Atlanta: Arthritis Foundation; 2001. p. 165-73.
3. Garcia Rodriquez LA, Williams R, Derby LE, et al. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994;154:311-6.
4. Phillips AC, Polisson RP, Smon LS. NSAIDs and the elderly. Toxicity and economic implications. Drugs Aging 1997;10(2):119-30.
5. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:13S-24S.
6. Wolfe NM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of the nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
7. Graham DY, Rakel RE, Fendrick AM, et al. Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis. Postgrad Med 1999;105(3):113-28.
8. Clauw DJ. Musculoskeletal signs and symptoms: E. Fibromyalgia and diffuse pain syndromes. In: Klippel JH, editor. Primer on the rheumatic diseases. 12th edition. Atlanta: Arthritis Foundation; 2001. p. 188-193.
9. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
10. International Committee for Standardization in Hematology. Recommendation for measurement of erythrocyte sedimentation rate of human blood. Am J Clin Pathol 1977; 68:505-6.
11. Bakerman S. Erythrocyte sedimentation rate (ESR). In: Bakerman S, editor. ABC's of interpretive laboratory data. 2nd edition. Greenville (NC): Interpretive Laboratory Data, Inc; 1984. p. 185-6.
12. Waddell G. An approach to backache. Br J Hosp Med 1982;28:187-90.
13. Fye KH. Evaluation of the patient. C. Laboratory assessment. In: Klippel JH, editor. Primer on the rheumatic diseases. 12th edition. Arthritis Foundation: Atlanta; 2001. p. 133-44.
14. Kushner HL. Acute phase response. Clin Aspects Autoimmunity 1989;3:20-30.
15. Mustard RA, Bohnen JMA, Haseeb S, et al. C-reactive protein levels predict postoperative septic complications. Arch Surg 1987;122:69.
16. Thelander U, Larsson S. Quantitation of C-reactive protein levels and erythrocyte sedimentation rate after spinal surgery. Spine 1992;17:400.
17. Okamura JM, Miyagi JM, Terada K, et al. Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990;4:231.
18. Bakerman S. Cerebrospinal fluid (CSF). In: Bakerman S, editor. ABC's of interpretive laboratory data. 2nd edition. Greenville (NC): Interpretive Laboratory Data, Inc; 1984. p. 113-6.
19. Ratnoff WD. Inherited deficiencies of complement in rheumatic diseases. Rheum Dis Clin North Am 1996;22:75-94.
20. Hansen KE, Arnasen J, Bridges AJ. Autoantibodies and common viral ilnesses. Semin Arthritis Rheum 1998;27:263-71.
21. von Muhlen CA, Tan ME. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthritis Rheum 1995;24:323-58.
22. Cooper C, Dennison E, Schafheutle K, et al. Epidemiology of Paget's disease of bone. Bone 1999;24:S3-5.
23. Eastell R. Biochenical markers of bone turnover in Paget's disease of bone. Bone 1999;24:49-50.
24. Terkeltaub RA. Gout. In: Klippel JH, editor. Primer on the rheumatic diseases. 12th edition. Atlanta: Arthritis Foundation; 2001. p. 307-12.
25. Swartz MK. Enzymes in cancer. Clin Chem 1973;19:10.
26. Van Lente F. Alkaline and acid phosphatase determination in bone disease. Orthop Clin North Am 1979;10:437-50.
27. Bakerman S. Calcium, total, serum. In: Bakerman S, editor. ABC's of interpretive laboratory data. 2nd edition. Greenville (NC): Interpretive Laboratory Data, Inc.; 1984. p. 99-100.
28. Edwards NL, Gout B. Clinical and laboratory features. In: Klippel JH, editor. Primer on the rheumatic diseases. 12th edition. Atlanta: Arthritis Foundation; 2001. p. 313-9.
29. Weinstein JM. Differential diagnosis and surgical treatment of primary benign and malignant neoplasms. In: Frymoyer JW, editor. The adult spine: principles and practice. New York: Raven; 1991. p. 829-60.